Physician profile
Daniel Lloyd Shuler
NPI 1346206018
$1,732.02
in general payments reported to CMS, 2019-2025
17 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $96.51 · 2021: $238 · 2022: $394 · 2023: $190 · 2024: $360 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $380.54 | 2021-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $215.29 | 2020-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Ironshore Pharmaceuticals INC. | $209.98 | 2019-2024 | |
| Pfizer INC. | $208.94 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $146.14 | 2021-2025 | |
| Corium, LLC | $126.50 | 2021-2024 | Azstarys |
| Tris Pharma INC | $83.14 | 2019-2025 | Onyda Xr |
| Sobi, INC | $66.12 | 2019-2023 | |
| Glaxosmithkline, LLC. | $52.59 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $47.66 | 2024-2025 | |
| Neos Therapeutics, LP | $45.31 | 2023 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Seqirus USA INC | $39.33 | 2021-2025 | Flucelvax |
| Teva Pharmaceuticals USA, INC. | $38.74 | 2021 | |
| Shire North American Group INC | $26.51 | 2019 | |
| Abbvie INC. | $20.00 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $13.59 | 2019 | |
| Genentech USA, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Shuler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.